U.S. Products

Health is Our Passion and Priority

Astellas Pharma US is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for our patients today and providing them with a brighter future tomorrow.

This commitment extends to providing resources for our patients and their physicians and caregivers that help them throughout the life cycle of their condition and beyond.

Below is a list of Astellas' products marketed in the U.S. This information is intended for U.S. residents only.

View Astellas products for the global market on our global website.

Cardiology

Lexiscan^® (regadenoson) injection

Lexiscan®

Immunology

ASTAGRAF XL^® (tacrolimus extended-release capsules)

ASTAGRAF XL®

Prograf^® (tacrolimus) capsules, granules and injection

Prograf®

Infectious Disease

AmBisome^® (amphotericin B) liposome for injection

AmBisome®

CRESEMBA^® (isavuconazonium sulfate)

CRESEMBA®

MYCAMINE^® (micafungin for injection) for intravenous use

MYCAMINE®

Oncology

XTANDI^® (enzalutamide) capsules

XTANDI®

XOSPATA^® (gilteritinib) tablets

XOSPATA®

PADCEV^® (enfortumab vedotin-ejfv)

PADCEV®

Urology

Myrbetriq^® (mirabegron extended-release tablets)

Myrbetriq^® Granules (mirabegron for extended-release oral suspension)

VESIcare^® (solifenacin succinate) tablets

Prescribing Information
Patient Information

VESIcare LS^TM (solifenacin succinate) oral suspension

Prescribing Information
Patient Information

This information is intended for U.S. residents only.

All trademarks are Astellas’ except:

AmBisome is a registered trademark of Gilead Sciences, Inc.
1 Astellas Way, Northbrook, IL 60062, an affiliate of Astellas Pharma US, Inc.